Skip to content
DataLookout
Menu

NCT07117344

Biomarkers in Ankylosing Spondylitis

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 7 words
    • Trial completed
    • Study completion date changed from estimate of Aug 30, 2026 to Jul 30, 2026
    • Secondary endpoints: details revised at 5 of 5 entries
  2. Minor Trial status changed: Recruiting → Active, Not Recruiting
    • Primary completion moved earlier from Jul 30, 2026 to May 20, 2026
    • Site details revised
    v5
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v4
  4. Notable Start date: Aug 15, 2025 to Jan 15, 2026
    • Trial status: Recruiting to Not Yet Recruiting
    • Study completion date: Jul 30, 2026 to Aug 30, 2026
    • Site details revised
    v3
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

In this study, we aimed to compare serum PGRN and TNF-α levels in AS patients with healthy controls and to determine the relationship between TNF-α inhibitor use and PGRN levels in AS patients.
Timeframe: Patient will be seen only once

Secondary (5)

Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
Ankylosing Spondylitis Disease Activity Scoring-CRP (ASDAS-CRP)
Bath Ankylosing Spondylitis Functional Index (BASFI)
Bath Ankylosing Spondylitis Metrology Index (BASMI)
Ankylosing Spondylitis Quality of Life Scale (ASQoL)

Arms and interventions

Patients with ankylosing spondylitis on TNF inhibitors

Participants will be seen at one time and serum PGRN and TNF levels will be measured from each of them by ELISA method.

patients with ankylosing spondylitis taking non-steroidal anti-inflammatory drugs

Participants will be seen at one time and serum PGRN and TNF levels will be measured from each of them by ELISA method.

Control

Participants will be seen at one time and serum PGRN and TNF levels will be measured from each of them by ELISA method.

Sites

1 site in 1 country

  • Kırşehir Ahi Evran UniversityKırşehir, Turkey (Türkiye)